
Adipogen/Z-VRPR-FMK/AG-CP3-0008-C500/500 µg
商品编号:
AG-CP3-0008-C500
品牌:
Adipogen Inc
市场价:
¥5400.00
美元价:
3240.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | Z-Val-Arg-Pro-DL-Arg-FMK.TFA;MALT1Inhibitor |
ProductType | Chemical |
Properties | |
Formula | C31H49FN10O6.C2HF3O2 |
MW | 676.8.114.0 |
Sequence | Z-Val-Arg-Pro-DL-Arg-fluoromethylketone |
CAS | 1381885-28-4(freebase) |
PurityChemicals | ≥90%(HPLC) |
Appearance | Whitetoslightlyyellowsolid. |
Solubility | Solubleinwater. |
Identity | DeterminedbyMS. |
InChiKey | DYQKGOBRZWMAHV-YTJMMMLMSA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | -20°C |
HandlingAdvice | Avoidfreeze/thawcycles. Hygroscopic. Protectfrommoisture. |
Use/StABIlity | Stableforatleast3yearsafterreceiptwhenstoredat-20°C. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
- SelectivecellpermeableandirreversIBLeMALT1inhibitor.
- InhibitsNF-κB-dependentgeneexpressionandaffectsthegrowth,proliferationandsurvivalofactivatedBcell-likediffuselargeBcelllymphomas(ABC-DLBCL)andgerminalcenterBcelllikediffuselargeBcelllymphoma(GCB-DLBCL)celllines.
- ShowntoinhibittheautoprocessingactivityofMCA2ac(calciumdependent)inTrypanosomabrucei.
ProductReferences
- TheproteolyticactivityoftheparacaspaseMALT1iskeyinTcellactivation:F.Rebeaud,etal.;Nat.Immunol.9,272(2008)
- EssentialroleofMALT1proteaseactivityinactivatedBcell-likediffuselargeB-celllymphoma:S.Hailfinger,etal.;PNAS106,19947(2009)
- SelectiveC-RelActivationviaMalt1ControlsAnti-FungalTH-17ImmunitybyDectin-1andDectin-2:S.I.Gringhuis,etal.;PLoSPathogens7,e1001259(2011)
- CrystalstructureofaTrypanosomabruceimetacaspase:K.McLuskey,etal.;PNAS109,7469(2012)
- MALT1SmallMoleculeInhibitorsSpecificallySuppressABC-DLBCLInVitroandInVivo:L.Fontan,etal.;CancerCell22,812(2012)
- TheproteaseactivityoftheparacaspaseMALT1iscontrolledbymonoubiquitination:C.Pelzer,etal.;J.Immunol.14,337(2012)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们